Watch this video to find out from Dr Vogelbaum how therapeutics can be delivered into the brain more effectively.
Crossing the blood-brain barrier: novel approaches for delivery of therapeutics directly to the brain
Dr. Vogelbaum has disclosed that he is/was a consultant/advisor for Celgene and Tocagen and has stock ownership of and received royalties/payments from Infuseon Therapeutics Inc.